Dr. Thomas Kipps is a distinguished researcher at the University of California, San Diego, United States, specializing in oncology, hematology, and immunotherapy, with a particular focus on chronic lymphocytic leukemia (CLL). With an exceptional record of 518 publications, 69,084 citations, and an h-index of 122, he is a globally recognized leader in cancer research. His work has significantly advanced understanding of leukemia biology, targeted therapies, and clinical treatment strategies. Collaborating with an extensive international network, his research has directly influenced clinical practices and therapeutic development. Kipps’ contributions hold profound societal impact by improving patient outcomes, advancing precision medicine, and shaping modern cancer care worldwide.
